Biodegradable indium-111 labeled microspheres for in vivo evaluation of distribution and elimination

被引：15
|
作者：
Thanoo, BC [1 ]
Doll, WJ [1 ]
Mehta, RC [1 ]
Digenis, GA [1 ]
DeLuca, PP [1 ]
机构：
[1] UNIV KENTUCKY,COLL PHARM,LEXINGTON,KY 40536
来源：
PHARMACEUTICAL RESEARCH | 1995年 / 12卷 / 12期
关键词：
D O I：
10.1023/A:1016237216352
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：2060 / 2064
页数：5
相关论文
共 50 条
  • [31] Comparison of renal accumulation of gastrin DOTA-derivatives labeled with indium-111 in rat renal cells
    Trejtnar, F.
    Zbynek, N.
    Laznickova, A.
    Laznicek, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S241 - S242
  • [32] Bioelimination of new receptor-specific peptides labeled with indium-111 and yttrium-88 in the kidney
    Trejtnar, F
    Laznicek, M
    Laznickova, A
    Maecke, HR
    Eisenwiener, K
    Reubi, JC
    Wenger, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1192 - 1192
  • [33] Indium-111 labeled DTPA- and DOTA-bombesin analogs for receptor scintigraphy and radiotherapy.
    Breeman, WA
    de Jong, M
    Bernard, HF
    Srinivasan, A
    Visser, TJ
    Krenning, EP
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 103P - 103P
  • [34] Synthesis, Characterization and Theranostic Evaluation of Indium-111 labeled Multifunctional Superparamagnetic Iron Oxide Nanoparticles (vol 42, pg 164, 2015)
    Zolata, H.
    Abbasi, Davani F.
    Afarideh, H.
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (04) : 420 - 420
  • [35] Use of Ficoll-Hypaque Indium-111 labeled leukocytes in the diagnosis of infected synthetic vascular grafts
    Stassi, Elizabeth
    Chandler, Kimberly
    Johnson, Geoffrey
    Hunt, Christopher
    Peller, Patrick
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [36] Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide
    Hinkle, GH
    Burgers, JK
    Neal, CE
    Texter, JH
    Kahn, D
    Williams, RD
    Maguire, R
    Rogers, B
    Olsen, JO
    Badalament, RA
    CANCER, 1998, 83 (04) : 739 - 747
  • [37] In vitro and in vivo characterization of indium-111 and technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging
    Aloj, L
    Panico, M
    Caraco, C
    Del Vecchio, S
    Arra, C
    Affuso, A
    Accardo, A
    Mansi, R
    Tesauro, D
    De Luca, S
    Pedone, C
    Visentin, R
    Mazzi, U
    Morelli, G
    Salvatore, M
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (01) : 93 - 98
  • [38] In vitro and in vivo characterization of indium-111 and technetium-99m labeled cck-8 derivatives for CCK-B receptor imaging
    Aloj, L
    Panico, M
    Caraco, C
    Zannetti, A
    Del Vecchio, S
    Di Nuzzo, C
    Arra, C
    Affuso, A
    Morelli, G
    Accardo, A
    Mansi, R
    Tesauro, D
    De Luca, S
    Pedone, C
    Salvatore, M
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (02) : 280 - 280
  • [39] Evaluation of a method of stem cell labelling with Indium-111 oxine:: effects on viability and proliferation
    Legrand, J. F.
    Cougnenc, O.
    Leleu, C.
    Prangere, T.
    Lemesle, G.
    Mouquet, F.
    Jude, B.
    Steinling, M.
    Marchandise, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S284 - S284
  • [40] Use of Take-set® system for radiopharmaceutical labelling: Example of indium-111 labeled pentetreotide (Octreoscan®) preparation
    Ben Reguiga, M.
    Besse, H.
    Stievenart, J-L.
    Le Guludec, D.
    Sinegre, M.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (09): : 580 - 583
12345